Function and molecular basis of action of vasopressin 4—8 and its analogues in rat brain

Progress in Brain Research

Volumn 119, Issue C, 1999, Pages 163-175

  Du, Yu Cang ^a   Yan, Qing Wu ^a   Qiao, Li Ya ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN[4 VALINE]; BRAIN DERIVED NEUROTROPHIC FACTOR; CALMODULIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE C; VASOPRESSIN DERIVATIVE;

AMNESIA; AVOIDANCE BEHAVIOR; BINDING SITE; BRAIN FUNCTION; DRUG BINDING; GENETIC TRANSCRIPTION; HORMONE ACTION; IMMEDIATE EARLY GENE; LEARNING; MEMORY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; REVIEW; SECOND MESSENGER; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION;

ANIMALS; ARGININE VASOPRESSIN; BRAIN CHEMISTRY; HORMONE ANTAGONISTS; PEPTIDE FRAGMENTS; RATS;

EID: 0032459443     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)61569-1     Document Type: Article

References (69)

1. Aiyar, N., Nambi, P., Stassen, F.L., Crooke, S.T., Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci. 39 (1986), 37–45.
2. Araujo, D.M., Chabot, J.G., Quirion, R., Potential neurotrophic factors in the mammalian central nervous system: Functional significance in the developing and aging brain. Int. Rev. Neurobiol. 32 (1990), 141–174.
3. Ayer-LeLievre, C., Olson, L., Ebendal, T., Seiger, A., Persson, H., Expression of the betanerve growth factor gene in hippocampal neurons. Science 240 (1988), 1339–1341.
4. Ballarin, M., Ernfors, P., Lindefors, N., Person, H., Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Exp. Neurol. 114 (1991), 35–43.
5. Beckwith, B.E., Till, R.E., Reno, C.R., Poland, R.E., Dose-dependent effects of DDVP on memory in healthy young adult males: A preliminary study. Peptides 11 (1990), 473–476.
6. Berridge, M., Second messenger dualism in neuro-modulation and memory. Nature 323 (1986), 294–295.
7. Brinton, R.E., Gee, K.W., Wamsley, J.K., Davis, T.P., Yamamura, H.I., Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography. Proc. Natl. Acad. Sci. USA 81 (1984), 7248–7252.
8. Brinton, R.E., Gehlert, D.R., Wamsley, J.K., Wan, Y.S., Yamamura, H.I., Vasopressin metabolite, VP49, binding sites in brain: Distribution distinct from that of parent peptide. Life Science 38 (1986), 443–452.
9. Burbach, J.P.H., Lebouille, J.L.M., Proteolytic conversion of arginine vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis. J. Biol. Chem. 258 (1983), 1487–1494.
10. Burbach, J.P.H., Kovacs, G.L., De Wied, D., A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide. Science 221 (1983), 1310–1312.
11. Burbach, J.P.H., Terwel, D., Lebouille, J.L.M., Measurement and distribution of vasopressin-converting aminopeptidase activity in rat brain. Biochem. Biophys. Res. Commun. 144 (1987), 726–731.
12. Butlen, D., Guillon, G., Rajerison, M., Jard, S., Sawyer, W.H., Manning, M., Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: Effects of highly potent analogues and competitive inhibitors. Mol. Pharmacol. 14 (1978), 1006–1017.
13. Chen, X.F., Chen, Z.F., Liu, R.Y., Du, Y.C., Neonatal administrations of a vasopressin analog (DDVP) and hypertonic saline enhance learning behavior in rats. Peptides 9 (1988), 717–721.
14. Chen, X.F., Tang, T., Zhang, J.W., Miao, H.H., Wang, T.X., Du, Y.C., ZNC(C)PR affects developmental changes of P46 phosphorylation in rat hippocampus. Mol. Reprod. Dev. 35 (1993), 251–256.
15. Creba, J.A., Downes, C.P., Hawkins, P.T., Brewster, G., Michell, R.H., Kirk, C.J., Rapid breakdown of phosphatidylinositol 4-phosphate and phosphatidyli-nositol 4,5-bisphosphate in rat hepatocytes stimulated by vasopressin and other Ca2+ mobilizing hormones. Biochem. J. 212 (1983), 733–747.
16. Curran, T., Morgan, J.T., Memories of fos. Bioessays 7 (1987), 255–258.
17. Curran, T., Reddy, E.P., Skalka, A.M., Curran, T., (eds.) The Oncogenc Handbook, 1987, Elsevier Science, Amsterdam, 307–325.
18. De Jong, W., Gaffori, O., van Ree, J.M., De Wied, D., Differentiation of behavioral and peripheral actions of neuropeptides generated from vasopressin in the brain. Schrier, R.W., (eds.) Vasopressin, 1985, Raven Press, New York, 189–194.
19. De Kloet, E.R., Rotteveel, F., Voorhuis, Th.D., Terlou, M., Topography of binding sites for neurohypo-physeal hormones in rat brain. Eur. J. Pharmacol. 110 (1985), 113–119.
20. De Kloet, E.R., Voorhuis, T.A.M., Burbach, J.P.H., De Wied, D., Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP(49), in rat brain. Neurosci. Lett. 56 (1985), 7–11.
21. De Wied, D., Gaffoni, O., Van Ree, J.M., de Jong, W., Central target for the behavioural effects of vasopressin neuropeptides. Nature 308 (1984), 276–278.
22. De Wied, D., Gaffori, O., van Ree, J.M., de Jong, W., Vasopressin antagonists block peripheral as well as central vasopressin receptors. Pharmacol. Biochem. Behav. 21 (1984), 393–400.
23. De Wied, D., Gaffori, O., Burbach, J.P.H., Kovacs, G.L., van Ree, J.M., Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J. Pharmacol. Exp. Ther. 241 (1987), 268–274.
24. De Wied, D., Elands, J., Kovacs, G., Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: Mediation by a cerebral neurohypophyseal hormone receptor. Proc. Natl. Acad. Sci. USA 88 (1991), 1494–1498.
25. Dorso, D.M., Majumdar, L.A., Petracca, P.M., Baskin, D.G., Cornett, L.E., Characterization and localization of 3H-arginine8-vasopressin binding to rat kidney and brain tissue. Peptides 4 (1983), 699–706.
26. Du, Y.C., Guo, N.N., Chen, Z.F., Autoradio-graphic approach to the developmental study on the binding sites of VP 4–8 in rat hippocampus. Acta Physiol. Sin. 46 (1994), 435–440.
27. Du, Y.C., Wu, J.H., Jiang, X.M., Gu, Y.J., Characterization of binding sites of a memory-enhancing peptide VP 4–8 in rat cortical synaptosomal membranes. Peptides 15 (1994), 1273–1279.
28. Ernfors, P., Wetmore, C., Olson, L., Persson, H., Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5 (1990), 511–526.
29. Ernfors, P., Bengzon, J., Kokaia, Z., Person, H., Lind-vall, O., Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epilep-togenesis. Neuron 7 (1991), 165–176.
30. Gaffori, O.J.W., De Wied, D., Time-related memory effects of vasopressin analogues in rats. Pharmacol. Biochem. Behav. 25 (1986), 1125–1129.
31. Gage, F.H., Buzsaki, G., Armstrong, D.M., NGF-dependent sprouting and regeneration in the hippocampus. Prog. Brain Res. 83 (1990), 357–370.
32. Greenberg, M.E., Ziff, E.B., Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science 234 (1986), 80–83.
33. Gu, B.X., Du, Y.C., Arginine-vasopressin C-terrninal peptide stimulates inositol phospholipid metabolism in rat hippocampus. Acta Biochem. Biophys. Sin. 23 (1991), 331–337.
34. Gu, B.X., Du, Y.C., The neuropeptide ZNC(C)PR can induce c-fos and c-src transcriptions in the hippcampus of new born rats. Acta Biochem. Biophys. Sin. 23 (1991), 537–542.
35. Guillon, G., Butlen, D., Cantau, B., Barth, T., Jard, S., Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: Relation to adenylate cyclase activation. Eur. J. Pharmacol. 85 (1982), 291–304.
36. Hengerer, B., Lindholm, D., Heumann, R., Ruther, U., Wagner, E.F., Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl. Acad. Sci. USA 87 (1990), 3899–3903.
37. Junig, J.T., Abood, L.G., Skrobala, A.M., Two classes of arginine vasopressin binding sites on rat brain membranes. Neurochem. Res. 10 (1985), 1187–1202.
38. Kirk, C.J., Mitchell, R.H., Hems, D.A., Phosphatidylinositol metabolism in rat hepatocytes stimulated by vasopressin. Biochem. J. 194 (1981), 155–165.
39. Kovacs, G.L., Veldhuis, H.D., Versteeg, D.H.G., De Wied, D., Facilitation of avoidance behavior by vasopressin fragments microinjected into limbicmidbrain structures. Brain Res. 371 (1986), 17–24.
40. Le Moal, M., Koob, G.F., Koda, L.Y., Bloom, F.E., Manning, M., Sawyer, W.H., Rivier, J., Vasopressor receptor antagonist prevents behavioural effects of vasopressin. Nature 291 (1981), 491–493.
41. Lin, C., Liu, R.Y., Du, Y.C., Cysteinyl methyl ester of VP 4–8, a potent agonist on the maintenance of passive avoidance in rats. Peptides 11 (1990), 633–639.
42. Liu, R.Y., Lin, C., Du, Y.C., Facilitation of arginine-vasopressin analogs on learning and memory in rats. Acta Pharmacol. Sin. 11 (1990), 97–100.
43. Morgan, J.I., Curran, T., Role of ion flux in the control of c-fos expression. Nature 322 (1986), 552–555.
44. Morgan, J.I., Cohen, D.R., Hempstead, J.L., Curran, T., Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237 (1987), 192–197.
45. Olson, L., NGF and the treatment of Alzheimer's disease. Exp. Neurol. 124 (1993), 5–15.
46. Olwin, B.B., Storm, D.R., Calcium binding to complexes of calmodulin and calmodulin binding proteins. Biochemistry 24 (1985), 8081–8086.
47. Pearlmutter, A.F., Constantini, M.G., Loeser, B., Characterization of 3H-AVP binding sites in particulate preparations of rat brain. Peptides 4 (1983), 335–341.
48. Pearlmutter, A.F., Szkrybaalo, M., Pettibone, G., Specific arginine vasopressin binding in particulate membrane from rat aorta. Peptide 6 (1985), 427–431.
49. Petracca, F.M., Baskin, D.G., Diaz, J., Dorsa, D.M., Ontogenetic changes in vasopressin binding site distribution in rat brain: An autoradiographic study. Dev. Brain Res. 23 (1986), 63–68.
50. Phillips, H.S., Hains, J.M., Laramee, G.R., Rosenthal, A., Winslow, J.W., Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science 250 (1990), 290–294.
51. Qiao, L.Y., Du, Y.C., Involvement of a GPCR in signal transduction induced by VP 4–8. Xu, X.J., Ye, Y.H., Tam, J.P., (eds.) Peptides: Biology and Chemistry, Proceedings of the 1996 Chinese Peptide Symposium. Chendu, China., 1996, ESCOM, Leiden in press.
52. Qiao, L.Y., Du, Y.C., Increase of mitogen-activated protein kinase activity in rat brain after injection of argipressin(4–8). Chin. Pharmacol. Acta 18 (1997), 380–384.
53. Qiao, L.Y., Chen, X.F., Gu, B.X., Wang, T.X., Du, Y.C., Effect of VP 4–8 administration on Ca2+CaM-dependent protein kinase II autophosphorylation in rat brain. Acta Physiol. Sin., 49, 1998 in press.
54. Rong, X.W., Chen, X.F., Du, Y.C., Potentiation of synaptic transmission by neuropeptide VP 4–8 (ZNC(C)PR) in rat hippocampal slices. NeuroReport 4 (1993), 1135–1138.
55. Sager, S.M., Sharp, F.R., Curran, T., Expression of c-fos protein in brain: Metabolic mapping at the cellular level. Science 240 (1988), 1328–1331.
56. Scott, J., Selby, M., Urdea, M., Quiroga, M., Bell, G.I., Rutter, W.J., Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature 302 (1983), 538–540.
57. Shewey, L.M., Dorsa, D.M., V1type vasopressin receptors in rat brain septum: Binding characteristics and effects on inositol phospholipid metabolism. J. Neuro-sci. 8 (1988), 1671–1677.
58. Stephens, L.R., Logan, S.D., Arginine-vasopressin stimulates inositol phospholipid metabolism in rat hippocampus. J. Neurochem. 46 (1986), 649–651.
59. Wang, P.L., Lai, L.H., Du, Y.C., Jiang, S.P., Xu, X, Conformation of ZNC(C)PR and molecular dynamics simulation. Chin. Biochem. J. 8 (1992), 619–623.
60. Wang, P.L., Du, Y.C., Lai, L.H., Xu, X.J., Structure-activity relationship of memory-enhancing peptide ZNC(C)PR analogs. Acta Pharmacol. Sin. 15 (1994), 311–316.
61. Wetmore, C., Ernfors, P., Persson, H., Olson, L., Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp. Neurol. 109 (1990), 141–152.
62. Worley, P.E., Baraban, J.M., Colvin, J.S., Snyder, S.H., Inositol trisphosphate receptor localization in brain: Variable stoichiometry with protein kinase C. Nature 325 (1987), 159–161.
63. Xu, L.F., Xu, C.J., Du, Y.C., Lin, C., Lu, Z.X., Conformational studies on pentapeptide ZNC(C)PR and [D-Arg]ZNC(C)PR from vasopressin by 2D NMR. Acta Biochem. Biophys. Sin. 22 (1990), 533–554.
64. Yan, Q.W., Qiao, L.Y., Du, Y.C., VP 4–8-induced branching signaling pathway was mediated by a putative GPCR in rat brain. Shimonishi, Y., (eds.) Peptides Chemistry, Proceedings of the First International Peptide Symposium, 1998, Kyoto, Japan in press.
65. Zhou, A.W., Guo, J., Wang, H.Y., Gu, B.X., Du, Y.C., Enhancement of NGF gene expression in rat brain by the memory-enhancing peptide VP(4–8). Peptides 16 (1995), 581–586.
66. Zhou, A.W., Guo, J., Du, Y.C., NLPR, an agonist of VP(4–8), increases NGF gene expression in memory-impaired rat brain. Biomed. Peptides, Proteins Nucleic Acids 1 (1995), 57–58.
67. Zhou, A.W., Guo, J., Du, Y.C., Chen, X.F., Effects of VP(4–8) analogs on NGF mRNA transcription in rat brain. Chin. J. Physiol. Sci. 12 (1996), 81–86.
68. Zhou, A.W., Li, W.X., Guo, J., Du, Y.C., Facilitation of VP(4–8) on gene expression of BDNF and NGF in rat brain. Peptides 18 (1997), 1179–1187.
69. Zlokovic, B.V., Banks, W.A., Kadi, H., Erchegyi, J., Mackic, J.B., McComb, J.G., Kastin, A.J., Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier. Brain Res. 590 (1992), 213–218.